Methods

Editorial Board/Cover 2
pp. CO2-CO2(1)

Table of Contents
pp. iii-iv(2)

Adeno-associated virus vectorology and gene therapy applications
pp. 145-145(1)
Author: Klein R.L.

Production methods for gene transfer vectors based on adeno-associated virus serotypes
pp. 146-157(12)
Author: Grimm D.

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
pp. 158-167(10)
Authors: Zolotukhin S.; Potter M.; Zolotukhin I.; Sakai Y.; Loiler S.; Fraites T.J.; Chiodo V.A.; Phillipsberg T.; Muzyczka N.; Hauswirth W.W.; Flotte T.R.; Byrne B.J.; Snyder R.O.

Autonomous parvovirus vectors
pp. 168-181(14)
Authors: Maxwell I.H.; Terrell K.L.; Maxwell F.

Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system
pp. 182-194(13)
Authors: Ruitenberg M.J.; Eggers R.; Boer G.J.; Verhaagen J.

Application of adeno-associated viral vectors in behavioral research
pp. 195-202(8)
Authors: Nair H.P.; Young L.J.

Adeno-associated virus-mediated gene transfer to the neonatal brain
pp. 203-207(5)
Authors: Li J.; Daly T.M.

Recombinant adeno-associated virus vector design and gene expression in the mammalian brain
pp. 208-218(11)
Authors: Paterna J-C.; Bu¨eler H.

Regulation of gene expression in adeno-associated virus vectors in the brain
pp. 219-226(8)
Authors: Haberman R.P.; McCown T.J.

Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain
pp. 227-236(10)
Authors: Fitzsimons H.L.; Bland R.J.; During M.J.

Adeno-associated virus vectors for gene transfer to the brain
pp. 237-247(11)
Authors: Okada T.; Nomoto T.; Shimazaki K.; Lijun W.; Lu Y.; Matsushita T.; Mizukami H.; Urabe M.; Hanazono Y.; Kume A.; Muramatsu S-i.; Nakano I.; Ozawa K.

Adeno-associated virus-mediated antiapoptotic gene delivery: in vivo gene therapy for neurological disorders
pp. 248-252(5)
Authors: Mochizuki H.; Miura M.; Shimada T.; Mizuno Y.

Gene therapy for treatment of cerebral ischemia using defective recombinant adeno-associated virus vectors
pp. 253-258(6)
Authors: Tsai T-H.; Chen S-L.; Xiao X.; Liu D-W.; Tsao Y-P.

Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseases
pp. 259-266(8)
Authors: Tang Y.; Schmitt-Ott K.; Qian K.; Kagiyama S.; Ian Phillips M.

Gene delivery to the eye using adeno-associated viral vectors
pp. 267-275(9)
Authors: Martin K.R.G.; Klein R.L.; Quigley H.A.

Development of hammerhead ribozymes to modulate endogenous gene expression for functional studies
pp. 276-285(10)
Authors: Fritz J.J.; Lewin A.; Hauswirth W.; Agarwal A.; Grant M.; Shaw L.

Measurements of vector-derived neurotrophic factor and green fluorescent protein levels in the brain
pp. 286-292(7)
Authors: Klein R.L.; Hamby M.E.; Sonntag C.F.; Millard W.J.; King M.A.; Meyer E.M.

Particle detection, number estimation, and feature measurement in gene transfer studies: optical fractionator stereology integrated with digital image processing and analysis
pp. 293-299(7)
Authors: King M.A.; Scotty N.; Klein R.L.; Meyer E.M.